General applicability of chicken egg yolk antibodies: the performance of IgY immunoglobulins raised against the hypoxia-inducible factor 1alpha by Camenisch, G et al.
University of Zurich





General applicability of chicken egg yolk antibodies: the
performance of IgY immunoglobulins raised against the
hypoxia-inducible factor 1alpha
Camenisch, G; Tini, M; Chilov, D; Kvietikova, I; Srinivas, V; Caro, J; Spielmann, P;
Wenger, R H; Gassmann, M
Camenisch, G; Tini, M; Chilov, D; Kvietikova, I; Srinivas, V; Caro, J; Spielmann, P; Wenger, R H; Gassmann, M.
General applicability of chicken egg yolk antibodies: the performance of IgY immunoglobulins raised against the
hypoxia-inducible factor 1alpha. FASEB J. 1999, 13(1):81-8.
Postprint available at:
http://www.zora.unizh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.unizh.ch
Originally published at:
FASEB J. 1999, 13(1):81-8
Camenisch, G; Tini, M; Chilov, D; Kvietikova, I; Srinivas, V; Caro, J; Spielmann, P; Wenger, R H; Gassmann, M.
General applicability of chicken egg yolk antibodies: the performance of IgY immunoglobulins raised against the
hypoxia-inducible factor 1alpha. FASEB J. 1999, 13(1):81-8.
Postprint available at:
http://www.zora.unizh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.unizh.ch
Originally published at:
FASEB J. 1999, 13(1):81-8
General applicability of chicken egg yolk antibodies: the
performance of IgY immunoglobulins raised against the
hypoxia-inducible factor 1alpha
Abstract
Avian embryos and neonates acquire passive immunity by transferring maternal immunoglobulins from
serum to egg yolk. Despite being a convenient source of antibodies, egg yolk immunoglobulins (IgY)
from immunized hens have so far received scant attention in research. Here we report the generation and
rapid isolation of IgY from the egg yolk of hens immunized against the alpha subunit of the human
hypoxia-inducible factor 1 (HIF-1alpha). Anti-HIF-1alpha IgY antibodies were affinity purified and
tested for their performance in various applications. Abundant HIF-1alpha protein was detected by
Western blot analysis in nuclear extracts derived from hypoxic cells of human, mouse, monkey, swine,
and dog origin whereas in hypoxic quail and frog cells, the HIF-1alpha signal was weak or absent,
respectively. In electrophoretic mobility shift assays, affinity-purified IgY antibody was shown to
recognize the native HIF-1 (but not the related HIF-2) complex that specifically binds an
oligonucleotide containing the HIF-1 DNA binding site. Furthermore, IgY antibody immunoprecipitated
HIF-1alpha from hypoxic cell extracts. Immunofluorescence experiments using IgY antibody allowed
the detection of HIF-1alpha in the nucleus of hypoxic COS-7 cells. For comparison, the application of a
mouse monoclonal antibody raised against the identical HIF-1alpha fragment was more restricted.
Because chicken housing is inexpensive, egg collection is noninvasive, isolation and affinity purification
of IgY antibodies are fast and simple, and the applicability of IgY is widespread, immunization of hens
represents an excellent alternative for the generation of polyclonal antibodies.
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ABSTRACT Avian embryos and neonates acquire
passive immunity by transferring maternal immuno-
globulins from serum to egg yolk. Despite being a
convenient source of antibodies, egg yolk immuno-
globulins (IgY) from immunized hens have so far re-
ceived scant attention in research. Here we report the
generation and rapid isolation of IgY from the egg
yolk of hens immunized against the a subunit of the
human hypoxia-inducible factor 1 (HIF-1a). Anti-
HIF-1a IgY antibodies were affinity purified and
tested for their performance in various applications.
Abundant HIF-1a protein was detected by Western
blot analysis in nuclear extracts derived from hypoxic
cells of human, mouse, monkey, swine, and dog ori-
gin whereas in hypoxic quail and frog cells, the HIF-
1a signal was weak or absent, respectively. In electro-
phoretic mobility shift assays, affinity-purified IgY an-
tibody was shown to recognize the native HIF-1 (but
not the related HIF-2) complex that specifically binds
an oligonucleotide containing the HIF-1 DNA binding
site. Furthermore, IgY antibody immunoprecipitated
HIF-1a from hypoxic cell extracts. Immunofluores-
cence experiments using IgY antibody allowed the de-
tection of HIF-1a in the nucleus of hypoxic COS-7
cells. For comparison, the application of a mouse
monoclonal antibody raised against the identical HIF-
1a fragment was more restricted. Because chicken
housing is inexpensive, egg collection is noninvasive,
isolation and affinity purification of IgY antibodies
are fast and simple, and the applicability of IgY is
widespread, immunization of hens represents an ex-
cellent alternative for the generation of polyclonal
antibodies.—Camenisch, G., Tini, M., Chilov, D.,
Kvietikova, I., Srinivas, V., Caro, J., Spielmann, P.,
Wenger, R. H., Gassmann, M. General applicability
of chicken egg yolk antibodies: the performance of
IgY immunoglobulins raised against the hypoxia-in-
ducible factor 1a. FASEB J. 13, 81–88 (1999)
Key Words: monoclonal antibody · affinity purification · West-
ern blotting · EMSA · immunoprecipitation · immunofluo-
rescence
MORE THAN A CENTURY AGO, Klemperer (1) observed
that immunized hens transfer immunoglobulins
(Ig)2 from the serum to the egg yolk. Despite being
classified as IgG-like immunoglobulins, the struc-
ture of chicken antibodies differs considerably from
that of mammalian IgG. For example, the molecular
mass of mammalian IgG heavy chain is about 50 kDa,
whereas from chicken it is 67–70 kDa (reviewed in
ref 2). Based on their well-defined structural differ-
ences compared to mammals, IgG-like antibodies
from birds (as well as from amphibians and reptiles)
were termed IgY (3). There are several advantages
of this technology (termed IgY technology, accord-
ing to ref 4) over conventional antibody production
that uses rabbits and other mammals: chicken hous-
ing is inexpensive, egg collection is noninvasive, and
IgY isolation is fast and simple. Moreover, due to the
phylogenetic distance, conserved mammalian pro-
teins often are more immunogenic in birds than in
mammals (5–8). Another advantage is that very low
quantities of antigen are required to obtain high
and longlasting IgY titers in the yolk from immu-
nized hens (5, 9, 10). Despite being an excellent
method of antibody production, chicken IgY anti-
bodies represent an underused resource. This may
be due to the lack of information concerning the
application of IgY antibodies or because IgY anti-
bodies do not bind to proteins A or G. The aim of
the present work was to provide a rapid protocol for
isolation and immune purification of chicken anti-
bodies as well as to test the performance of IgY an-
tibodies in a variety of applications. For comparison,
1 Correspondence: Institute of Physiology, University of Zu¨-
rich-Irchel, Winterthurerstrasse 190, 8057 Zu¨rich, Switzerland.
E-mail: labbauer@physiol.unizh.ch
2 Abbreviations: AhR, aryl hydrocarbon receptor; ARNT,
AhR nuclear translocator; ATCC, American Type Culture Col-
lection; ELISA, enzyme-linked immunosorbant assay; EMSAs,
electrophoretic mobility shift assays; GST, glutathione S-trans-
ferase; HIF-1a, hypoxia-inducible factor 1a; Ig, immunoglob-
ulin; PBS, phosphate-buffered saline; SDS, sodium dodecyl
sulfate.
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we generated a mouse monoclonal antibody against
the same antigen.
Hens and mice were immunized against the a sub-
unit of the human hypoxia-inducible factor 1 (HIF-
1a). The heterodimeric transcription factor HIF-1,
consisting of the two subunits a and b, represents the
master regulator of oxygen homeostasis (reviewed in
ref 11). Null mutant mice lacking either the HIF-1a
(12, 13) or the HIF-1b subunit (14, 15) die shortly
after midgestation. Unexpectedly, whereas HIF-1a
represents a newly detected protein, HIF-1b was
found to be identical to the heterodimerization part-
ner of the dioxin receptor/aryl hydrocarbon re-
ceptor (AhR), termed AhR nuclear translocator
(ARNT) (16). Upon hypoxic exposure, HIF-1 in-
duces mRNA expression of a variety of oxygen-de-
pendent genes including erythropoietin, vascular
endothelial growth factor, and transferrin (11).
Transactivation occurs by binding to an HIF-1 DNA
binding site (CGTG) present in the regulatory
regions of such hypoxically regulated genes. In con-
trast to these genes, HIF-1 is not regulated at the
mRNA but at the protein level (17).
Here we demonstrate that the affinity-purified anti-
HIF-1a IgY antibody allowed detection of HIF-1apro-
tein in Western blots, electrophoretic mobility shift
assays (EMSAs), immunoprecipitation, and immu-
nofluorescence experiments using hypoxic cells from
different species. In contrast, the application of the
mouse monoclonal antibody was more restricted.
MATERIALS AND METHODS
Antigen preparation
A polymerase chain reaction-amplified EcoRI-HpaI fragment
of the HIF-1a cDNA spanning the carboxyl-terminal amino
acids 530 to 825 of human HIF-1a (16) was cloned into the
EcoRI-SmaI site of the bacterial overexpression vector
pGEX4T1 (Pharmacia, Piscataway, N.J.). The resulting plas-
mid overexpressed HIF-1a as a fusion protein with glutathione
S-transferase (GST) in the bacterial strain BL21(DE3)plysS
(Novagen, Madison, Wis.) after induction with isopropyl-b-D-
1-thiogalactopyranoside. The bacteria were pelleted, resus-
pended in phosphate-buffered saline (PBS) containing 50
mM Tris-HCl (pH 8.0), 10 mM EDTA, and 1 mM phenylme-
thylsulfonyl fluoride, and lysed in a French press. The GST-
HIF-1a fusion protein was purified using glutathione Sepha-
rose 4B (Pharmacia) according to the manufacturer’s
instructions. For further purification, the GST-HIF-1a530–825
antigen was electrophoresed through a preparative sodium
dodecyl sulfate (SDS) polyacrylamide gel and the correspond-
ing band was excised, minced with a polytron (Kinematika,
Kriens, Switzerland), and lyophilized.
Immunization of hens and isolation of IgY from egg yolks
Approximately 80 mg of GST-HIF-1a fusion protein was resus-
pended in 500 ml PBS and mixed with an equal volume of
complete Freund’s adjuvant (Behring Diagnostics, Sommer-
ville, N.J.). Laying white leghorn hens obtained from a local
breeder were immunized by injecting the antigen into the pec-
toral muscle. Two booster injections of 60 mg antigen mixed
with incomplete Freund’s adjuvant were given 2 and 4 wk
later. The eggs were collected daily and stored at 47C for up
to 6 months until antibody extraction.
Isolation of polyclonal chicken immunoglobulins from in-
dividual eggs was performed by a simple two-step procedure
modified from an earlier protocol (18). The egg yolk was sep-
arated from the egg white, washed with deionized water, and
placed in a funnel. The skin of the egg yolk was removed with
forceps and the yolk was collected in a 50 ml screw cap tube.
The yolk volume was brought to 25 ml with sodium phosphate
buffer (100 mM, pH 7.6) and mixed vigorously. Subsequently,
20 ml of chloroform was added and the mixture was shaken
until a semisolid phase was obtained. After centrifugation at
1200 1 g for 30 min, the supernatant was decanted into a
centrifugation tube and solid polyethylene glycol 6000 (Fluka,
St. Louis, Mo.) was added to a final concentration of 12% (w/
v). After centrifugation at 15,700 1 g for 10 min, the pellet
was resuspended in 2 ml sodium phosphate buffer and stored
at 0807C.
Affinity purification of IgY antibodies
One gram of freeze-dried cyanogen bromide-activated Se-
pharose 4B (Pharmacia) was reswollen according to the man-
ufacturer’s instructions, thereby yielding 3.5 ml of resin. Re-
combinant fusion protein (2.5 mg) containing the human
HIF-1a carboxyl terminus was dialyzed against the coupling
buffer (0.5 M NaCl, 0.1 M NaHCO3, pH 8.3) and added to the
reswollen Sepharose. After end-to-end rotation for 2 h at room
temperature and centrifugation at 401 g for 5 min, the pellet
was incubated with 10 ml of blocking agent (0.2 M glycine,
pH 8.0) at 47C for 16 h to inactivate the remaining active
groups of the resin. The resin was poured into a column and
unspecifically bound proteins were washed out by repeating
five times an alternating washing procedure consisting of a
washing step with 5 ml coupling buffer, followed by one with
5 ml acetate buffer (0.5 M NaCl, 0.1 M ammonium acetate,
pH 4.0). After rinsing the column with 50 ml PBS, isolated IgY
fractions from four eggs were pooled (8 ml), brought to 50
ml with PBS, and loaded overnight at 47C at a flow rate of 30
ml/min. The column was washed with 50 ml PBS, and bound
IgY antibodies were eluted with 8.5 ml of elution buffer (0.15
M NaCl, 0.2 M glycine, pH 2.2). For immediate neutralization,
the eluted fractions (2 ml) were poured into 15 ml tubes con-
taining 0.8 ml of 1 M Tris-HCl buffer (pH 8.0). The column
was neutralized with Tris buffer, washed with PBS, stored in
PBS containing 0.05% NaN3 at 47C, and washed with PBS be-
fore re-use. Prior to storage of the affinity-purified IgY anti-
body (/47C or 0807C), 0.1 mg/ml bovine serum albumin was
routinely added as a carrier.
Generation of the monoclonal antibody mgc3
HIF-1a (100 mg) antigen was resuspended in 0.5 ml complete
Freund’s adjuvant and injected subcutaneously into mice. Ad-
ditional aliquots of 100 mg of antigen were resuspended in
incomplete adjuvant and administered 21 and 42 days later.
After decapitation, isolated splenocytes were fused to mye-
loma X65Ag8 cells, as described (19), and supernatants from
the resulting hybridoma cell lines were screened for the pres-
ence of specific antibodies against HIF-1a by enzyme-linked
immunosorbant assay (ELISA) using standard methodology.
The positive clone was isotyped (using IsoStrip from Boeh-
ringer Mannheim, Mannheim, Germany), revealing a mono-
clonal IgG1 antibody (named mgc3), and affinity purified us-
ing a protein A Sepharose column (Pharmacia).
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Cell culture and hypoxic exposure
The human epitheloid carcinoma cell line HeLa and the Af-
rican green monkey cell line COS-7 were obtained from Amer-
ican Type Culture Collection in Rockville, Md. (ATCC num-
bers CCL-2 and CRL-1651, respectively). The mouse
hepatoma cell line Hepa1 (also termed Hepa1c1c7) was a kind
gift of L. Poellinger (Stockholm), the porcine kidney cells
LLC-PK1 (ATCC CL-101) and the canine kidney cells MDCK
(ATCC CCL-34) were kindly provided by J. Forgo (Zu¨rich),
and the quail sarcoma cell line QT6 (ATCC CRL-1708) and
the Xenopus laevis kidney cell line A6C1 (ATCC CCL-102) were
obtained from L. Vogt and B. Spindler (Zu¨rich), respectively.
All cell lines were cultured in Dulbecco’s modified Eagle’s
medium (DMEM, high glucose, Life Technologies, Paisley,
U.K.) supplemented with 10% heat-inactivated fetal calf se-
rum (Boehringer-Mannheim), 11minimal essential medium
nonessential amino acids, 2 mM L-glutamine, 1 mM natrium
pyruvate, 100 U/ml penicillin, and 100 mg/ml streptomycin
(all Gibco-BRL). Except for frog A6C1, the cell lines were cul-
tured in a humidified atmosphere containing 5% CO2 at 377C.
Oxygen tensions in the incubators (Forma Scientific, model
3319) were either 140 mm Hg (20% O2 v/v, normoxia) or 7
mm Hg (1% O2 v/v, hypoxia). Routinely, cells were subjected
to hypoxic induction for 4 h at a density of approximately 1–2
1 105 cells/cm2.
The kidney cell line A6C1 derived from X. laevis was cul-
tured at 287C in 5% CO2 in air. To mimic hypoxia, cells were
exposed to 130 mM deferoxamine mesylate (Sigma, St. Louis,
Mo.) for 6 h.
HeLaS3 cells (ATCC CCL-2.2), a subline of the HeLa cell
line that was adapted to grow in suspension, were cultured in
Ham’s F-12 medium supplemented as described above. Hy-
poxic induction of HeLaS3 cells was performed as previously
described (20). In brief, approximately 107 cells/ml were dis-
continuously stirred in a tonometer (Instrumentation Labo-
ratory, model IL 237) at 377C using gas mixtures of either 20%
O2, 5% CO2, and 75% N2 (normoxia) or 0.5% O2, 5% CO2,
and 94.5% N2 (hypoxia) for 4 h at a flow rate of 500 ml/min.
Cellular fractionation, in vitro translation, Western blot
analysis, and EMSA
Nuclear extracts from hypoxic and normoxic cells were iso-
lated as previously described (20). For total protein lysates,
the culture medium was removed and the cells were washed
twice with ice-cold PBS. Ice-cold lysis buffer consisting of 10
mM Tris-HCl (pH 8.0), 1 mM EDTA, 150 mM NaCl, 1% Triton
X-100, 1% sodiumdeoxycholate, 0.1% SDS, 1 mM phenylme-
thylsulfonyl fluoride, 0.5 mM dithiothreitol, 2 mg/ml leupep-
tin, 2 mg/ml aprotinin, 2 mg/ml pepstatin, and 1 mM Na3VO3
(all from Sigma) was added and the cells were kept on ice for
10 min. The lysates were collected, sonicated, and centrifuged
with 700 1 g at 47C for 10 min. The supernatant was frozen at
0807C.
In vitro transcription and translation of the recombinant
HIF-1a and b subunits were performed using the plasmids
pBSKhHIF1aT7 (16), pBSK-HLF (21), and pBSArntKS/ (22)
and the TNT-coupled transcription-translation rabbit reticu-
locyte lysate system (Promega, Southampton, U.K.), following
the manufacturer’s instructions.
Extracts were electrophoresed through SDS polyacrylamide
gel and electrotransferred to nitrocellulose membranes
(Schleicher & Schuell, Keene, N.H.) using standard proce-
dures. The Western blot was blocked with blocking buffer (4%
w/v instant nonfat milk powder in PBS) and incubated for 2
h with the affinity-purified IgY antibody or the hybridoma
mgc3 supernatant in blocking buffer. The membranes were
washed and subsequently incubated with horseradish peroxi-
dase-coupled rabbit anti-chicken antibodies (Promega,
G1351) for IgY detection or goat anti-mouse antibodies
(Pierce, 31430) for mgc3 detection for 1 h. HIF-1a protein
was detected using enhanced chemiluminescence (Pierce,
34080). To test their acidic resistance, affinity-purified IgY
containing bovine serum albumin (final concentration of 2%)
were adjusted to pH 2.35 and neutralized again after the in-
dicated periods of time. Immediately after neutralization, the
antibodies were diluted in PBS containing 4% milk powder.
For Western blot analysis of bacterially expressed fusion
protein, cDNA fragments of human HIF-1a corresponding to
amino acids 530–653 and 530–825, as well as a 575–793 mouse
HIF-2a fragment, were cloned in frame to the carboxyl ter-
minus of GST (pGEX4T1, Pharmacia). Alternatively, HIF-
1a530–652, HIF-1a530–825, or HIF-2a576–874 fragments were cloned
in frame to the carboxyl terminus of a (His)6 tag (pQE32,
Qiagen, Chatsworth, Calif.). Bacterial expression and fusion
protein purification were performed as described by the man-
ufacturers (Pharmacia and Qiagen, respectively).
EMSA analysis was performed exactly as described, using an
erythropoietin gene-derived oligonucleotide containing the
HIF-1 DNA binding site (20). For supershifts analysis, each 1
ml of affinity-purified IgY antibody or mgc3 supernatant was
added to the binding reaction.
Immunoprecipitation
Hypoxic COS-7 cells were washed three times with PBS and
lysed by exposure for 10 min to ice-cold lysis buffer consisting
of 10 mM Tris-HCl (pH 8.0), 1 mM EDTA, 150 mM NaCl, 1%
Triton X-100, 1% sodiumdeoxycholate, 1% SDS, 1 mM phen-
ylmethylsulfonyl fluoride, 1 mg/ml leupeptin, 1 mg/ml apro-
tinin, and 1 mg/ml pepstatin (all from Sigma). The lysate was
sonicated and centrifuged at 10,000 1 g for 20 min at 47C.
Total cell lysate (1 mg) was incubated with 30 ng of affinity-
purified IgY antibody overnight on ice. A rabbit anti-chicken
antibody (Promega, C2691) was added to the mixture for 2 h
on ice. Protein A Sepharose (Pharmacia) was added and in-
cubation was continued by rotation for 30 min at 47C. The
precipitate was centrifuged at 15,000 1 g; the pellet was
washed three times with total cellular lysis buffer (see above)
and twice with 10 mM Tris-HCl (pH 7.5). Finally, the precip-
itates were analzed by Western blotting using IgY antibody.
Similarly, 350 mg of total cellular lysate from HeLa cells was
incubated with 50 ml hybridoma mgc3 supernatant overnight
on ice. Protein A/G Sepharose (30 ml) (Santa Cruz) was al-
lowed to bind for 3 h at 47C and the precipitates were analzed
by Western blot, as described above, using the monoclonal
mgc3 antibody for HIF-1a detection.
Indirect immunofluorescence microscopy
Hypoxic COS-7 cells were fixed with 4% formaldehyde (pH
8.0) for 10 min at room temperature, washed three times with
PBS, permeabilized with 0.5% Triton X-100 (Fluka) in PBS
for 5 min, and rinsed three times with PBS. To block nonspe-
cific binding, PBS containing 10% fetal calf serum was added
for 30 min. Cells were then incubated with or without the
affinity-purified IgY antibody (diluted 1:10 in PBS) at 377C for
1 h. HeLa cells were fixed as described above and then incu-
bated with or without affinity-purified mgc3 antibody diluted
1:10 in PBS.
Primary antibodies were detected using either an FITC-
conjugated rabbit anti-chicken antibody (Promega, G2691)
or Cy3-conjugated donkey anti-mouse antibody (Jackson
Immunoresearch Laboratory, West Grove, Pa.). Secondary an-
tibodies were incubated at room temperature for 30 min,
washed extensively in PBS and mounted in DABCO solution
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Figure 1. Western blot analysis of affinity-purified
anti-human HIF-1a IgY antibody. A) Nuclear ex-
tracts (100 mg) from hypoxic HeLaS3 cells were
incubated with affinity-purified IgY antibody at the
dilutions indicated. B) Affinity-purified IgY anti-
bodies containing 0.1 mg/ml bovine serum albu-
min as carrier were incubated at pH 2.35 for the
period of time indicated. After neutralization, the
antibodies were tested at a dilution of 1:50.
Figure 2. Both the polyclonal and the monoclonal anti-HIF-
1a antibodies recognize HIF-1a but not HIF-2a. A) Nuclear
extracts (5 mg) from normoxic or hypoxic HeLa cells were
analyzed by electrophoretic mobility shift assay. Addition of
the monoclonal antibody mgc3 supershifted the HIF-1 het-
erodimer, whereas DNA binding activity of the HIF-1 complex
drastically decreased upon incubation with the chicken poly-
clonal anti-HIF-1a antibody. B) Both antibodies recognized
the recombinant HIF-1 complex formed by heterodimeriza-
tion of in vitro translated HIF-1a and ARNT. In contrast, the
a subunit of the HIF-2 heterodimer was not recognized by the
monoclonal or the polyclonal anti-HIF-1a antibody.
(Sigma). Immunofluorescent staining was detected by confo-
cal laser scanning microscopy.
RESULTS
White leghorn hens were immunized with human
GST-HIF-1a fusion protein. Isolation of IgY antibod-
ies from individual eggs was performed by a simple
two-step procedure that consisted of a chloroform
extraction of the egg yolk, followed by a single poly-
ethylene glycol precipitation step (see Materials and
Methods). Using this procedure, IgY antibodies were
purified to better than 90% homogeneity (data not
shown). Western blot analysis revealed the presence
of specific IgY antibodies in eggs collected 10 days
after the last boost injection. Because strong unspe-
cific signals were obtained with nuclear fractions de-
rived from HeLaS3 cells, the IgY antibodies were af-
finity purified. The same fusion protein used for
immunization was bound to a resin and specific IgY
antibody was eluted using an acidic buffer (pH 2.2).
Pooled polyethylene glycol fractions from four egg
yolks yielded 14–16 ml affinity-purified IgY antibody,
which detected HIF-1a in nuclear extracts from hy-
poxic HeLaS3 cells at a dilution as high as 1:1000
(Fig. 1). In addition to nuclear fractions, the affinity-
purified IgY antibody also allowed detection of HIF-
1a protein in total cellular extracts from hypoxic
HeLaS3 cells (data not shown). We also generated a
mouse monoclonal antibody termed mgc3, which was
raised against the same human HIF-1a fragment as
that used for hen immunization. Like the IgY anti-
body, mgc3 recognized HIF-1a protein in nuclear
and total cellular extracts from human HeLaS3 cells
previously exposed to hypoxia (data not shown).
The stability of IgY antibodies to acidic denatura-
tion has been described to be lower than that of rab-
bit IgG (10, 23), implying that acidic elution from the
affinity column (see above) might be harmful to the
IgY antibodies. To test their tenacity toward low pH
conditions, affinity-purified IgY were exposed to pH
2.35. Western blot analysis using nuclear extracts
from hypoxic HeLaS3 cells showed only slight reduc-
tion of HIF-1a signals when IgY antibodies that
underwent acidic exposure for up to 3 h were used
(Fig. 1).
Next, we analyzed whether the affinity-purified IgY
antibody was capable of recognizing native HIF-1a
protein in electrophoretic mobility shift assays (EM-
SAs), using as probe an HIF-1 DNA binding oligo-
nucleotide derived from the erythropoietin gene, as
described (20). After incubation of the probe with
nuclear extracts from normoxic or hypoxic HeLa
cells, the expected nonspecific, constitutive, and hyp-
oxia-inducible factors (20) were detected (Fig. 2A).
Addition of the chicken polyclonal antibody partially
abolished binding of the HIF-1 heterodimer to the
HIF-1 DNA binding site and partially supershifted the
HIF-1 complex, whereas the constitutive and the non-
specific factors were not affected (Fig. 2A). On the
other hand, addition of the monoclonal antibody
mgc3 recognized HIF-1a protein in the same hypoxic
HeLa extract and resulted solely in a supershifted
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Figure 3. Western blot analysis of bacterially expressed GST and (His)6 fusion proteins. The blots were incubated with
the polyclonal IgY or the monoclonal mgc3 antibodies. For comparison, a Coomassie-stained polyacrylamide gel of
the purified proteins is shown on the left.
HIF-1 complex. Analogous results were obtained
when adding IgY antibody or mgc3 to hypoxic nu-
clear extracts from the mouse hepatoma cell line
Hepa1 (data not shown). Thus, the carboxyl-terminal
HIF-1a fragment contains residues that are necessary
for functional formation of the HIF-1 complex.
Recently, four groups independently isolated a
novel endothel-specific transcription factor that is
similar to HIF-1a and was hence termed HIF-2a
(reviewed in ref 11). HIF-2a, like HIF-1a, forms a
functional heterodimer with ARNT (termed HIF-
2), is activated by hypoxia, and transactives oxygen-
dependent genes by utilizing the same DNA bind-
ing site as HIF-1 (21). To rule out cross-reactivity
of our IgY and IgG antibodies between both hyp-
oxia-inducible transcription factors, we performed
EMSAs using in vitro synthesized HIF-1a, HIF-2a,
and ARNT. As shown in Fig. 2B, the monoclonal
mgc3 and the polyclonal IgY antibody were able to
recognize in vitro translated HIF-1a but not HIF-2a
protein. These results were confirmed by Western
blot analysis with deletion constructs of bacterially
expressed fusion proteins. As shown in Fig. 3, both
antibodies were specific for HIF-1a and did not
cross-react with HIF-2a. Even though the poly-
clonal IgY antibody was affinity purified using the
GST-HIF-1a fusion protein, its cross-reactivity with
GST alone was very weak, indicating that the GST
protein per se displays a low immunogenicity in
chicken. In contrast to the IgY antibody, mgc3
failed to react with the 530–653 HIF-1a fragment,
indicating that the mgc3 epitope is localized be-
tween amino acids 654 and 825.
As mentioned above, both antibodies recognized
native HIF-1a protein present in hypoxic extracts de-
rived from human HeLa or mouse Hepa1 cell lines.
Unexpectedly, and in contrast to the EMSA results
described in Fig. 2A, the monoclonal antibody mgc3
repeatedly failed to react with denatured HIF-1a pro-
tein in Western blot analysis when using extracts from
hypoxic mouse Hepa1 cells (Fig. 4A). Probably the
specific mouse HIF-1a epitope was altered upon pro-
tein denaturation by SDS. Thus, the different mam-
malian, avian and amphibian cell lines were exam-
ined by the affinity-purified chicken IgY antibody
only. To this end, human (HeLaS3), monkey (COS-
7), swine (LLCPK), dog (MDCK), and quail (QT6)
cells were exposed to hypoxia (1% oxygen) for 4 h.
In the case of the X. laevis cell line A6C1, which re-
quires a culture temperature of 287C, hypoxic con-
ditions were mimicked by addition of deferoxamine
(130 mM for 6 h), an iron chelator known to induce
hypoxically regulated genes including HIF-1a (24).
Western blot analysis using affinity-purified IgY and
nuclear extracts derived from induced cells detected
abundant HIF-1a protein in all mammalian cells
tested. In contrast, the HIF-1a protein signal in in-
duced quail and frog cells was very weak or absent,
respectively (Fig. 4B). That HIF-1-like DNA binding
activity has been observed in induced Drosophila me-
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Figure 4. The polyclonal but not the monoclonal anti-HIF-1a
antibody recognizes HIF-1a from a variety of species. A) Nu-
clear extracts (25 mg) from mouse hepatoma (Hepa1) and
human cervical carcinoma (HeLaS3) cells were subjected to
7.5% SDS-PAGE; HIF-1a was detected in Western blots using
either polyclonal or monoclonal antibodies. Whereas poly-
clonal anti-HIF-1a (IgY) antibody recognized HIF-1a in hu-
man and mouse cells, the monoclonal antibody mgc3
repeatedly detected denatured HIF-1a in human cells only.
B) Anti-HIF-1a IgY antibodies recognize HIF-1a protein in
hypoxic extracts from human cervical carcinoma (HeLaS3),
African green monkey kidney (COS-7), pig kidney (LLCPK1),
dog kidney (MDCK), and quail sarcoma (QT6) but not in
Xenopus laevis kidney (A6C1) cell lines. Total cell lysates (50
mg) were resolved by 7.5% SDS-PAGE and Western blots were
analyzed with affinity-purified IgY antibodies at a dilution of
1:100. Overexposure of the Western blot confirmed the pres-
ence of a faint band in quail but not in frog cells (data not
shown).
Figure 5. Immunoprecipitation of HIF-1 by polyclonal (IgY)
and monoclonal (mgc3) anti-HIF-1a antibodies. HIF-1a pro-
tein was induced in COS-7 and HeLa cells by exposure to 1%
O2 for 4 h. Total cell lysates from COS-7 and HeLa cells were
incubated with anti-HIF-1a (IgY) antibody or hybridoma mgc3
supernatant, respectively. The immunoprecipitates were ana-
lyzed by Western blot analysis using the same antibodies as
used for immunoprecipitation.
Figure 6. Polyclonal and monoclonal anti-HIF-1a
antibodies localize HIF-1 to the nucleus of hypoxic
COS-7 and HeLa cells, respectively. After hypoxic
stimulation (1% O2 for 4 h), cells were incubated
with either polyclonal anti-HIF-1a or protein A af-
finity-purified monoclonal mgc3 antibodies, as in-
dicated and visualized by confocal laser scanning
microscopy.
lanogaster SL2 cells (25), however, suggests that an
HIF-1-like mechanism is widespread throughout the
animal kingdom. Assuming that this notion is cor-
rect, our data imply that the HIF-1a carboxyl-termi-
nal part (used as antigen) is highly conserved within
the mammalian species.
Chicken IgY antibodies do not bind protein A or
G. To circumvent this disadvantage in immunopre-
cipitation experiments, we made use of a commer-
cially available rabbit anti-chicken IgY antibody. Total
cellular lysates from hypoxic COS-7 cells were incu-
bated with IgY antibody (30 ng) overnight, followed
by a 2 h incubation with rabbit anti-chicken antibod-
ies. Immunoprecipitation was performed by adding
protein A Sepharose to the mixture and the precip-
itates were analyzed by Western blotting. As shown in
Fig. 5, the affinity-purified IgY antibody was able to
immunoprecipitate HIF-1a. We also demonstrated
that, despite some background signals, the monoclo-
nal antibody mgc3 also immunoprecipitated the HIF-
1a protein present in total cellular lysates from hu-
man HeLa cells.
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Finally, the affinity-purified IgY antibody was tested
for its ability to detect HIF-1a in the African green
monkey cell line COS-7 by immunofluorescence. As
shown in Fig. 6, HIF-1a protein was localized in the
nucleus of COS-7 cells that were previously exposed
to hypoxia (1% oxygen) for 4 h. No signal was ob-
tained when omitting the primary antibody. Similar
results were obtained when immunofluorescence was
performed with hypoxic HeLa cells using the mono-
clonal antibody mgc3. This data demonstrates that,
upon hypoxic exposure, HIF-1a is translocated to the
nucleus.
DISCUSSION
Based on its simplicity and rapidity, we optimized a
modified chloroform polyethylene glycol protocol
(18) that very efficiently enriched for chicken im-
munoglobulins. Note, however, that there are several
alternative extractions methods to separate the water
soluble proteins including IgY from lipids that are
present in high concentrations in the egg yolk (26,
27). As shown recently (28), the use of a crude IgY
fraction in Western blot analysis might generate non-
specific staining. Unspecific reactions in immuno-
histochemical studies might also occur when using
crude IgY fractions (29). Nonspecificity staining was
circumvented by affinity purification of the chicken
antibodies using a GST-HIF-1a affinity column. Apart
from GST-based fusion protein, a synthetic peptide
(26 amino acids) has also been used successfully to
affinity purify IgY antibodies, which in turn allowed
purification of human a2-antiplasmin (30).
Unlike mammals, the Fc fragment of hens and most
birds does not bind protein A or G (31). Therefore,
after incubation of the extracts with IgY antibodies,
we added commercially available rabbit anti-chicken
antibodies, which allowed immunoprecipitation of
HIF-1a with protein A beads. Similarly, the use of a
crude IgY fraction and protein G-Sepharose beads
preabsorbed with goat anti-chicken antibodies al-
lowed immunoprecipitation of neurofibromatosis
type 3 protein (32). It is noteworthy that duck im-
munoglobulins have been reported to bind to pro-
tein A or G; however, this high affinity was not attrib-
uted to the Fc fragment but to unique histidine
residues occuring predominantly in the CH1 domain
(31). Nonetheless, immunization of ducks is not rec-
ommended since they lay eggs during a short period
of the year and since duck-specific housing is de-
manding.
Apart from the methods used in this work, IgY an-
tibodies have been successfully applied in a variety of
assays such as radioimmunoassay (RIA), ELISA, in-
direct hemagglutination assay, and immunodiffusion
(7, 33–36), as well as in immunogold labeling exper-
iments (37). From a therapeutic point of view, egg
yolk from immunized hens has been proposed to be
a convenient vehicle for oral passive immunization
against enteral germs (10, 38, 39) or even against
dental plaque formation in humans (40). Egg yolk
antibodies from hens immunized with rattlesnake or
scorpion venom have been used to generate anti-
venoms that neutralize the lethal effects of these ven-
oms in vivo (41).
When comparing different adjuvants for chicken
immunization, the use of complete Freund’s adju-
vants was reported to yield the highest IgY titers (42).
In view of its tissue-damaging property, which is not
necessarily observed macroscopically, the use of al-
ternative adjuvants has been proposed recently (42).
Considering animal welfare, it should be pointed out
that chicken can be kept under conventional condi-
tions without special veterinary support. If required,
chicken housing and immunization can be out-
sourced. Despite their general applicability, IgY an-
tibodies are scarcely used. We hope that the protocols
presented in this work will help to increase the ac-
ceptance of the IgY technology.
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